Caprolactam Chemicals Ltd
Caprolactam Chemicals Limited was promoted as Vamotiwala Chemicals Industries Limited as a small scale industry in the year 1992. The company specializes in the manufacturing of industrial chemicals like Glycol Ethers and Ethylene Oxide Condensate Emulsifiers. Caprolactam Chemicals has customer base only in India.
- Market Cap ₹ 24.3 Cr.
- Current Price ₹ 52.8
- High / Low ₹ 64.8 / 43.0
- Stock P/E
- Book Value ₹ 11.6
- Dividend Yield 0.00 %
- ROCE 6.86 %
- ROE 3.67 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 4.57 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.04% over past five years.
- Company has a low return on equity of 11.4% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.38 | 3.92 | 2.85 | 4.88 | 3.23 | 4.07 | 5.19 | 6.51 | 6.31 | 2.07 | 9.84 | 6.96 | 5.76 | |
2.71 | 4.03 | 2.46 | 4.05 | 2.76 | 3.18 | 3.31 | 3.99 | 4.14 | 2.64 | 5.17 | 4.79 | 3.98 | |
Operating Profit | 0.67 | -0.11 | 0.39 | 0.83 | 0.47 | 0.89 | 1.88 | 2.52 | 2.17 | -0.57 | 4.67 | 2.17 | 1.78 |
OPM % | 19.82% | -2.81% | 13.68% | 17.01% | 14.55% | 21.87% | 36.22% | 38.71% | 34.39% | -27.54% | 47.46% | 31.18% | 30.90% |
0.05 | 0.01 | -0.15 | 0.40 | 0.01 | 0.07 | 0.07 | 0.06 | 0.09 | 0.41 | 0.02 | 0.18 | 0.03 | |
Interest | 0.00 | 0.00 | 0.06 | 0.11 | 0.12 | 0.19 | 0.34 | 0.30 | 0.30 | 0.28 | 0.57 | 0.50 | 0.51 |
Depreciation | 0.22 | 0.19 | 0.23 | 0.51 | 0.47 | 0.57 | 0.97 | 1.02 | 1.07 | 1.03 | 1.15 | 1.58 | 1.60 |
Profit before tax | 0.50 | -0.29 | -0.05 | 0.61 | -0.11 | 0.20 | 0.64 | 1.26 | 0.89 | -1.47 | 2.97 | 0.27 | -0.30 |
Tax % | 16.00% | -6.90% | 0.00% | 14.75% | 0.00% | 15.00% | 23.44% | 24.60% | 26.97% | -12.93% | 14.14% | 29.63% | |
0.42 | -0.27 | -0.06 | 0.52 | -0.12 | 0.17 | 0.50 | 0.95 | 0.65 | -1.28 | 2.55 | 0.20 | -0.27 | |
EPS in Rs | 0.91 | -0.59 | -0.13 | 1.13 | -0.26 | 0.37 | 1.09 | 2.07 | 1.41 | -2.78 | 5.54 | 0.43 | -0.59 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 6% |
3 Years: | 3% |
TTM: | -33% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | -17% |
3 Years: | -32% |
TTM: | -123% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 21% |
3 Years: | -8% |
1 Year: | -6% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 11% |
Last Year: | 4% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
Reserves | -2.81 | -3.08 | -3.13 | -2.61 | -2.73 | -2.56 | -2.06 | -1.10 | -0.52 | -1.80 | 0.74 | 0.95 | 0.72 |
0.02 | 0.09 | 0.82 | 0.95 | 1.37 | 1.89 | 3.58 | 2.45 | 2.15 | 3.76 | 5.69 | 5.86 | 7.15 | |
0.40 | 0.52 | 1.15 | 0.98 | 1.10 | 2.35 | 1.29 | 1.16 | 0.97 | 3.77 | 0.49 | 0.24 | 0.88 | |
Total Liabilities | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.65 | 13.35 |
1.38 | 1.19 | 2.92 | 2.96 | 3.38 | 3.56 | 6.37 | 6.07 | 5.50 | 5.26 | 10.22 | 10.29 | 10.11 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.96 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.82 | 0.93 | 0.51 | 0.95 | 0.95 | 2.71 | 1.04 | 1.04 | 1.70 | 1.11 | 1.30 | 1.36 | 3.24 | |
Total Assets | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.65 | 13.35 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.56 | -0.13 | 1.44 | 0.58 | 0.54 | 1.10 | 2.96 | 2.18 | 1.25 | 3.05 | 0.86 | 1.82 | |
0.00 | 0.00 | -2.16 | -0.56 | -0.89 | -0.75 | -3.78 | -0.73 | -0.48 | -4.75 | -2.14 | -1.64 | |
-0.52 | 0.07 | 0.68 | 0.02 | 0.30 | 0.33 | 0.35 | -1.43 | -0.59 | 1.33 | 1.37 | -0.32 | |
Net Cash Flow | 0.04 | -0.06 | -0.05 | 0.05 | -0.05 | 0.68 | -0.47 | 0.02 | 0.18 | -0.37 | 0.08 | -0.14 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 32.40 | 25.14 | 1.28 | 38.89 | 40.68 | 69.05 | 2.81 | 16.82 | 27.19 | 5.29 | 25.22 | 33.56 |
Inventory Days | 104.29 | 304.17 | 88.78 | 82.64 | 53.85 | 52.14 | ||||||
Days Payable | 43.45 | 861.81 | 799.05 | 344.34 | 173.52 | 111.73 | ||||||
Cash Conversion Cycle | 32.40 | 85.97 | 1.28 | 38.89 | 40.68 | -488.58 | -707.46 | 16.82 | 27.19 | -256.41 | -94.45 | -26.03 |
Working Capital Days | 38.88 | 28.86 | -84.53 | -0.75 | -14.69 | -62.78 | -22.50 | -20.75 | 17.93 | -513.12 | 17.80 | 40.38 |
ROCE % | 27.10% | -17.06% | 11.34% | 27.64% | 0.32% | 10.91% | 19.52% | 25.85% | 19.54% | -18.61% | 40.25% | 6.86% |
Documents
Announcements
-
Non Submission Of Related Party Transaction In XBRL Mode Under Reg. 23(9) For The Period Ended 30Th September, 2024
16 Nov - Non-submission of Related Party Transaction disclosures.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Newspaper Advertisement of the Unaudited Financial Result for half and quarter ended on 30th September, 2024
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Newspaper Advertisement of the Unaudited Financial Result for half and quarter ended on 30th September, 2024
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 12Th November, 2024
12 Nov - Approval of unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Unaudited Financial Results For The Half Year Ended 30Th September, 2024 And Recommend Payment Of Dividend If Any.
4 Nov - Board meeting to approve financial results and dividend.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview [1]
Caprolactam Chemicals is engaged in manufacturing of chemicals and provides Job work services as per customers requirement.
Caprolactam offers ready to use facilities for Contract Manufacturing to the industries like Flavors & Fragrance, Aroma, Pharma & Agro-Chemicals.
Company did 6.5 Cr turnover in FY20 which was jobwork income.